63 related articles for article (PubMed ID: 25859976)
1. High content screening biosensor assay to identify disruptors of p53-hDM2 protein-protein interactions.
Hua Y; Strock CJ; Johnston PA
Methods Mol Biol; 2015; 1278():555-65. PubMed ID: 25859976
[TBL] [Abstract][Full Text] [Related]
2. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
[TBL] [Abstract][Full Text] [Related]
4. High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.
Hua Y; Camarco DP; Strock CJ; Johnston PA
Methods Mol Biol; 2018; 1683():211-227. PubMed ID: 29082495
[TBL] [Abstract][Full Text] [Related]
5. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53.
Boyd SD; Tsai KY; Jacks T
Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695
[TBL] [Abstract][Full Text] [Related]
6. High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.
Hua Y; Shun TY; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2014 Sep; 12(7):395-418. PubMed ID: 25181412
[TBL] [Abstract][Full Text] [Related]
7. Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.
Bhatt P; d'Avout C; Kane NS; Borowiec JA; Saxena A
FEBS J; 2012 Feb; 279(3):370-83. PubMed ID: 22103682
[TBL] [Abstract][Full Text] [Related]
8. Using BRET to study chemical compound-induced disruptions of the p53-HDM2 interactions in live cells.
Mazars A; Fåhraeus R
Biotechnol J; 2010 Apr; 5(4):377-84. PubMed ID: 20235143
[TBL] [Abstract][Full Text] [Related]
9. A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions.
Lundholt BK; Heydorn A; Bjørn SP; Praestegaard M
Assay Drug Dev Technol; 2006 Dec; 4(6):679-88. PubMed ID: 17199506
[TBL] [Abstract][Full Text] [Related]
10. Case Study: discovery of inhibitors of the MDM2-p53 protein-protein interaction.
Liu L; Bernard D; Wang S
Methods Mol Biol; 2015; 1278():567-85. PubMed ID: 25859977
[TBL] [Abstract][Full Text] [Related]
11. Efficient and dynamic nuclear localization of green fluorescent protein via RNA binding.
Kitamura A; Nakayama Y; Kinjo M
Biochem Biophys Res Commun; 2015 Jul; 463(3):401-6. PubMed ID: 26032495
[TBL] [Abstract][Full Text] [Related]
12. The central region of HDM2 provides a second binding site for p53.
Yu GW; Rudiger S; Veprintsev D; Freund S; Fernandez-Fernandez MR; Fersht AR
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1227-32. PubMed ID: 16432196
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited.
Middeler G; Zerf K; Jenovai S; Thulig A; Tschödrich-Rotter M; Kubitscheck U; Peters R
Oncogene; 1997 Mar; 14(12):1407-17. PubMed ID: 9136984
[TBL] [Abstract][Full Text] [Related]
14. Visualization and targeted disruption of protein interactions in living cells.
Herce HD; Deng W; Helma J; Leonhardt H; Cardoso MC
Nat Commun; 2013; 4():2660. PubMed ID: 24154492
[TBL] [Abstract][Full Text] [Related]
15. N-alkylated oligoamide alpha-helical proteomimetics.
Campbell F; Plante JP; Edwards TA; Warriner SL; Wilson AJ
Org Biomol Chem; 2010 May; 8(10):2344-51. PubMed ID: 20448891
[TBL] [Abstract][Full Text] [Related]
16. Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction.
Green AI; Hobor F; Tinworth CP; Warriner S; Wilson AJ; Nelson A
Chemistry; 2020 Aug; 26(47):10682-10689. PubMed ID: 32458465
[TBL] [Abstract][Full Text] [Related]
17. Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.
Mo XL; Luo Y; Ivanov AA; Su R; Havel JJ; Li Z; Khuri FR; Du Y; Fu H
J Mol Cell Biol; 2016 Jun; 8(3):271-81. PubMed ID: 26578655
[TBL] [Abstract][Full Text] [Related]
18. Multivalent helix mimetics for PPI-inhibition.
Barnard A; Miles JA; Burslem GM; Barker AM; Wilson AJ
Org Biomol Chem; 2015 Jan; 13(1):258-64. PubMed ID: 25408290
[TBL] [Abstract][Full Text] [Related]
19. A highly potent and cellularly active beta-peptidic inhibitor of the p53/hDM2 interaction.
Hintersteiner M; Kimmerlin T; Garavel G; Schindler T; Bauer R; Meisner NC; Seifert JM; Uhl V; Auer M
Chembiochem; 2009 Apr; 10(6):994-8. PubMed ID: 19267375
[TBL] [Abstract][Full Text] [Related]
20. An α-Helix-Mimicking 12,13-Helix: Designed α/β/γ-Foldamers as Selective Inhibitors of Protein-Protein Interactions.
Grison CM; Miles JA; Robin S; Wilson AJ; Aitken DJ
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11096-100. PubMed ID: 27467859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
